Molecular mechanism of drug tolerance in dormant mycobacteria and identification of the drug target
Molecular mechanism of drug tolerance in dormant mycobacteria and identification of the drug target
批准号:
21590486
负责人:
MATSUMOTO Sohkichi
金额:
$2.91万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2009
资助国家:
日本
项目状态:
已结题
起止时间:
2009 至 2011
中文摘要
结核病是在世界各地发现的致命传染病,仍然是一个主要的公共卫生问题。虽然异烟肼(INH)是治疗结核病的关键药物,但对异烟肼的耐受性导致疗程延长,是有效进行结核病化疗的一个令人担忧的问题。异烟肼是一种前药,由分枝杆菌酶KatG激活。我们已经证明,分枝杆菌DNA结合蛋白1(MDP1)是一种在分枝杆菌中保守的组蛋白样蛋白,它负向调节KatG转录,并导致分枝杆菌对异烟肼的表型耐受。与野生型相比,mdp1缺失的耻垢分枝杆菌表现出更高的KatG表达和更强的INH活性。耻垢分枝杆菌稳定期MDP1的表达增加,使其对异烟肼的耐受性呈生长时相依赖性。污垢分枝杆菌和结核分枝杆菌复合体之间对KatG表达的调控是保守的。在牛分枝杆菌卡介苗中,MDP1的人工减少导致了KatG表达的增加和对异烟肼的易感性。这些数据证明了分枝杆菌对异烟肼的表型耐受机制是通过一种类似组蛋白的蛋白实现的。
英文摘要
Tuberculosis is deadly infectious diseases found worldwide and remains a leading public health problem. Although isoniazid(INH) is a key drug for the treatment of tuberculosis(TB), tolerance against INH that causes prolonged treatment duration is a concern for effective TB chemotherapy. INH is a prodrug and is activated by the mycobacterial enzyme, KatG. We have shown that mycobacterial DNA-binding protein 1(MDP1), which is a histone-like protein conserved in mycobacteria, negatively regulates KatG transcription and leads to phenotypic tolerance to INH in mycobacteria. Mycobacterium smegmatis deficient for MDP1 exhibited increased expression of KatG and showed enhanced INH activation compared to the wild-type strain. Expression of MDP1 was increased in the stationary phase and conferred growth phase-dependent tolerance of M. smegmatis to INH. Regulation of KatG expression is conserved among M. smegmatis and Mycobacterium tuberculosis complex. Artificial reduction of MDP1 in Mycobacterium bovis BCG was shown to lead to increased KatG expression and susceptibility to INH. These data demonstrate the phenotypic tolerance mechanism to INH of mycobacteria by a histone-like protein.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Clinical practice for the diagnosis of latent mycobacterium tuberculosis infection
潜伏结核分枝杆菌感染诊断的临床实践
DOI:
--
发表时间:
2010
期刊:
影响因子:
--
作者:
[Osada-Oka M, Hirayama Y, Kitada S, Tateishi Y, Maekura R, Sugimura H, Koide Y, Kobayashi K, Matsumoto S]
通讯作者:
Matsumoto S
結核菌感染における制御性T細胞の関与
调节性 T 细胞参与结核分枝杆菌感染
DOI:
--
发表时间:
2010
期刊:
影响因子:
--
作者:
[尾関百合子, 菅原勇, 岡真優子, 小林和夫, 松本壮吉]
通讯作者:
松本壮吉
Growth inhibition of HeLa cell by internalization of Mycobacterium bovis Bacillus Calmette-Guerin (BCG) Tokyo.
通过内化牛分枝杆菌卡介苗 (BCG) 东京来抑制 HeLa 细胞的生长。
DOI:
--
发表时间:
2009
期刊:
Cancer Cell Int 9
影响因子:
--
作者:
[Kitamura, A., S.Matsumoto., et al.]
通讯作者:
et al.
Molecular mechanisms of latent tuberculiosis infection(LTBI) and development of diagnosis of LTBI
潜伏性结核感染(LTBI)的分子机制及LTBI诊断进展
DOI:
--
发表时间:
2010
期刊:
影响因子:
--
作者:
[Yanagisawa N, Haruta I, Kikuchi K, Shibata N, Yagi J, 松本壮吉]
通讯作者:
松本壮吉
人獣共通感染症, 非結核性抗酸菌症改訂版
人畜共患病、非结核分枝杆菌疾病修订版
DOI:
--
发表时间:
2011
期刊:
影响因子:
--
作者:
[西内由紀子, 立石善隆, 山田毅, 松本壮吉症, 木村哲, 喜田宏編集]
通讯作者:
喜田宏編集
共 55 条
Research in Kenya for the development of diagnosis of latent and active tuberculosis
-
批准号:23406011
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.73万
-
财政年份:2011
-
负责人:MATSUMOTO Sohkichi
-
依托单位:
海外基金